Cellectis SA
OTC:CMVLF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cellectis SA
OTC:CMVLF
|
FR |
|
R
|
RBC Bearings Inc
F:B1X
|
US |
|
I
|
Intron Technology Holdings Ltd
F:B46
|
HK |
|
M
|
Maat Pharma SA
PAR:MAAT
|
FR |
|
Shockwave Medical Inc
F:36M
|
US |
|
23andMe Holding Co.
NASDAQ:ME
|
US |
|
E
|
Erdene Resource Development Corp
F:E8KA
|
CA |
|
Kofola CeskoSlovensko as
LSE:0RD3
|
CZ |
|
BioRestorative Therapies Inc
F:9OF
|
US |
|
Max Financial Services Ltd
NSE:MFSL
|
IN |
|
PTT PCL
SET:PTT
|
TH |
|
B
|
British Land Company PLC
OTC:BRLAF
|
UK |
Wall St Price Targets
CMVLF Price Targets Summary
Cellectis SA
According to Wall Street analysts, the average 1-year price target for CMVLF is 9.55 USD with a low forecast of 9.45 USD and a high forecast of 9.83 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CMVLF's stock price target?
Price Target
9.55
USD
According to Wall Street analysts, the average 1-year price target for CMVLF is 9.55 USD with a low forecast of 9.45 USD and a high forecast of 9.83 USD.
What is the Revenue forecast for Cellectis SA?
Projected CAGR
-29%
Over the last 14 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 3 years is -29%.
What is the Gross Profit forecast for Cellectis SA?
Projected CAGR
162%
The compound annual growth rate for Gross Profit over the next 1 year is 162%.
